Keyphrases
Nanoparticles
100%
Targeted Delivery
100%
Paclitaxel
100%
Tariquidar
100%
Simultaneous Delivery
100%
Tumor Drug Resistance
100%
Anticancer Drugs
42%
Dual Agent
42%
P-glycoprotein Inhibitor
42%
Tumor Cells
28%
Biotin
28%
Drug-resistant Tumor
28%
Mouse Model
14%
P-glycoprotein (P-gp)
14%
Overexpression
14%
Drug Resistance
14%
Third Generation
14%
Drug Transporters
14%
Cancer Chemotherapy
14%
Functionalized Nanoparticles
14%
Therapeutic Efficacy
14%
Early Phase Clinical Trials
14%
Poly(d,l-lactide-co-glycolide)
14%
Cytotoxicity in Vitro
14%
Efflux Pump Inhibitors
14%
Inhibitor Combination
14%
Active Tumor Targeting
14%
Drug Inhibitors
14%
Tumor Inhibition
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Paclitaxel
100%
Tariquidar
100%
Neoplasm
100%
Drug Resistance
100%
P-Glycoprotein
37%
Anticarcinogen
37%
Effusion
25%
Biotin
25%
Clinical Trial
12%
Cancer Chemotherapy
12%
Mouse Model
12%
Tumor Growth
12%
Polyglactin
12%
Glycoprotein P Inhibitor
12%
Combination Therapy
12%
Cytotoxicity
12%